Adrian Haigh - May 16, 2024 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
CHIEF OPERATING OFFICER
Signature
/s/ Adrian Haigh
Stock symbol
FENC
Transactions as of
May 16, 2024
Transactions value $
$0
Form type
4
Date filed
5/21/2024, 05:05 PM
Previous filing
Apr 22, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Stock Option Award $0 +50K +13.88% $0.00 410K May 16, 2024 Common Shares 50K $7.12 Direct F1, F2
transaction FENC Restricted Shste Unit Award $0 +25K +6.09% $0.00 435K May 16, 2024 Common Shares 25K $0.00 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 16, 2024, Adrian Haigh was granted incentive stock options to purchase 50,000 shares of the issuer's common shares pursuant to the issuer's 2020 Equity Incentive Plan.
F2 2. One-third of the shares subject to this option may be exercised as of May 16, 2025 (the "Vesting Commencement Date"). One twenty-fourth of the shares subject to this option may be exercised as of the last day of each month following the Vesting Commencement Date. As of April 30, 2027 and thereafter, 100% of the total number of shares subject to this option shall be vested.
F3 On May 16, 2024, Adrina Haigh was awarded restricted share units to acquire 25,000 shares of the issuer's common shares pursuant to the issuer's 2020 Equity Incentive Plan
F4 One-third of the shares subject to this award shall be released from restriction as of May 16, 2025 (the "Vesting Commencement Date"). One twenty-fourth of the shares subject to this award may be released from restriction as of the last day of each month following the Vesting Commencement Date. As of April 30, 2027 and thereafter, 100% of the total number of shares subject to this award shall be released from restriction..